✦ LIBER ✦

Predictors of early recurrence in postmenopausal women with hormone receptor positive breast cancer in the BIG 1-98 trial

✍ Scribed by L. Mauriac; Keshaviah; M. Debled; H. Mouridsen; J. Forbes; B. Thuerlimann; R. Paridaens; R. Gelber; M. Castiglione-Gertsch; A. Goldhirsch

Book ID: 118624521
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 141 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)80241-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patterns and predictors of early recurre

Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer

✍ James Mansell; Ian J. Monypenny; Anthony I. Skene; Paul Abram; Robert Carpenter; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 206 KB

Patterns and predictors of early recurre

Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer

✍ James Mansell; Ian J. Monypenny; Anthony I. Skene; Paul Abram; Robert Carpenter; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 206 KB

O-32 Predictors of early recurrence in p

O-32 Predictors of early recurrence in postmenopausal women with ER+ early stage breast cancer

✍ J. Mansell; I.J. Monypenny; A.I. Skene; P. Abram; J. Gattuso; A. Abdel-Rahman; C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

The role of endocrine therapies in reduc

The role of endocrine therapies in reducing risk of recurrence in postmenopausal women with hormone receptor-positive breast cancer

✍ Emma Pennery 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 363 KB

Interpreting breast international group

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

✍ Meredith M Regan; Karen N Price; Anita Giobbie-Hurder; Beat Thürlimann; Richard 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 368 KB

Optimal adjuvant hormonal therapy in pos

Optimal adjuvant hormonal therapy in postmenopausal women with hormone-receptor-positive early breast cancer: have we answered the question?

✍ Alfonso Sánchez-Muñz; Nuria Ribelles; Emilio Alba 📂 Article 📅 2010 🏛 Springer Milan 🌐 Spanish ⚖ 561 KB